one

Compendium of research projects at the interface of tuberculosis and COVID-19

As the world comes together to tackle the COVID-19 pandemic, it is important to ensure that tuberculosis (TB) prevention and care approaches are adapting appropriately to ensure continuous and safe delivery of high-quality TB services. Considering the overlaps in TB and COVID-19 in disease presentation and transmission, the pandemic presents many questions for the TB

Compendium of research projects at the interface of tuberculosis and COVID-19 Read More »

Massive proportion of world’s population are living with herpes infection 3

Massive proportion of world’s population are living with herpes infection

Virus causing genital herpes may put millions of people at greater risk of infection with HIV About half a billion people worldwide are living with genital herpes, and several billion have an oral herpes infection, new estimates show. Authored by staff at the University of Bristol, World Health Organization (WHO), and Weill Cornell Medical College-Qatar,

Massive proportion of world’s population are living with herpes infection Read More »

Indonesia firmly committed to eliminating lymphatic filariasis as a public health problem 4

Indonesia firmly committed to eliminating lymphatic filariasis as a public health problem

Indonesia recently completed the last of its annual large-scale treatment for lymphatic filariasis (also known as elephantiasis or Penyakit Kaki Gajah) in Malaka District located in its southernmost province, East Nusa Tenggara. Unprecedented progress by the National Lymphatic Filariasis Elimination Programme has strongly placed the country on the path to achieving the elimination of lymphatic filariasis

Indonesia firmly committed to eliminating lymphatic filariasis as a public health problem Read More »

New estimates highlight need to step up the response to hepatitis D

Lyon, France, 29 April 2020 – In a study published in the Journal of Hepatology, 1 Professor Anna Maria Geretti and Dr Alexander Stockdale from the University of Liverpool (United Kingdom), in collaboration with researchers from the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC), estimate that worldwide, hepatitis D

New estimates highlight need to step up the response to hepatitis D Read More »

Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19 6

Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19

Heads of state and global health leaders today made an unprecedented commitment to work together to accelerate the development and production of new vaccines, tests and treatments for COVID-19 and assure equitable access worldwide. The COVID-19 pandemic has already affected more than 2.4 million people, killing over 160,000. It is taking a huge toll on

Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19 Read More »

Commitment and call to action: Global collaboration to accelerate new COVID-19 health technologies 7

Commitment and call to action: Global collaboration to accelerate new COVID-19 health technologies

Our Vision and Mission Grounded in a vision of a planet protected from human suffering and the devastating social and economic consequences of COVID-19, we, an initial group of global health actors (BMGF, CEPI, Gavi, Global Fund, UNITAID, Wellcome Trust, WHO) and private sector partners and other stakeholders, are launching a landmark, global and time-limited

Commitment and call to action: Global collaboration to accelerate new COVID-19 health technologies Read More »

INFOSAN Quarterly Summary, 2020 #1

Food safety incidents During the first quarter of 2020, the INFOSAN Secretariat was involved in 38 food safety incidents involving 109 WHO Member States and 9 territories of WHO Member States. There were 25 incidents involving a biological hazard (Salmonella spp. [8], Listeria monocytogenes [5], Norovirus [3] Shiga-toxin producing Escherichia coli [2], Clostridium botulinum [2]

INFOSAN Quarterly Summary, 2020 #1 Read More »

Shopping Cart